4//SEC Filing
Bisaccia Lisa 4
Accession 0001127602-21-012689
CIK 0000064803other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:57 PM ET
Size
20.8 KB
Accession
0001127602-21-012689
Insider Transaction Report
Form 4
Bisaccia Lisa
SVP, Chief HR Officer
Transactions
- Tax Payment
Common Stock
2021-04-01$74.30/sh−35,120$2,609,416→ 64,983 total - Award
Common Stock
2021-02-01+77,457→ 100,103 total - Tax Payment
Common Stock
2021-04-01$74.30/sh−1,190$88,417→ 66,417 total
Holdings
- 469.036
Phantom Stock Credits
Exercise: $1.00→ Common Stock (469.036 underlying) - 55,098
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (55,098 underlying) - 64,222
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (64,222 underlying) - 34,241
Stock Option
Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (34,241 underlying) - 655(indirect: Direct)
ESOP Common Stock
- 141,405
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (141,405 underlying) - 3,523
Common Stock (restricted)
- 98,558
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (98,558 underlying) - 39,433
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (39,433 underlying) - 23,942(indirect: By GRAT)
Common Stock
- 32,145.773
Stock Unit
Footnotes (12)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
- [F10]Option became exercisable in four equal annual installments, commencing 4/1/2020.
- [F11]The number of shares subject to the option were calculated using a 30-day average price.
- [F12]Options became exercisable in four equal annual installments, commencing 4/1/2021.
- [F2]Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
- [F3]Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
- [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F5]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F6]Option became exercisable in four equal annual installments, commencing 4/1/2016.
- [F7]Option became exercisable in four equal annual installments, commencing 4/1/2017.
- [F8]Option became exercisable in four equal annual installments, commencing 4/3/2018.
- [F9]Option became exercisable in four equal annual installments, commencing 4/1/2019.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001479663
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:57 PM ET
- Size
- 20.8 KB